NCT06937437

Brief Summary

The aim of the study is to determine the effectiveness of telespeech therapy on the treatment of stammering.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2025

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 22, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2025

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2025

Completed
Last Updated

July 15, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

April 7, 2025

Last Update Submit

July 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stuttering Severity Instrument - Fourth Edition (SSI4)

    The Stuttering Severity Instrument-Fourth Edition (SSI-4) is a norm-referenced assessment used to quantify stuttering severity in children and adults, measuring frequency, duration, physical concomitants, and the naturalness of speech. The total score measures the overall severity of the individual's stuttering disorder. The examiner adds scores from the frequency, duration, and physical concomitants sections to obtain the severity score and percentile rank. These are calculated using the tables within the record form. These tables also convert scores to a severity equivalent, which ranges from "very mild" to "very severe". It has a total score range of 0 to 20 for physical concomitants, and 2 to 18 for frequency and duration. The total score for the entire instrument is the sum of these three scores, making the overall range up to 20 + 18 + 18 = 56.

    Base line and 6 weeks

Study Arms (2)

Tele therapy

EXPERIMENTAL

The experimental group will be given teletherapy, total number of 2 sessions per week, each participant comprising 30 minutes.

Other: Teletherapy

Traditionally speech therapy

ACTIVE COMPARATOR

Traditional therapy will be given a total of 2 sessions per week to each participant, comprised of 30 minutes

Other: Traditionally speech therapy

Interventions

A teletherapy patient presenting with stammering (stuttering) is a person receiving speech therapy remotely, using technology like video conferencing, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech.

Tele therapy

This type of intervention is traditional speech therapy that will be given to stammering adults, to address speech fluency difficulties, often including repetitions, prolongations, or blocks in speech.

Traditionally speech therapy

Eligibility Criteria

Age15 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Both Genders
  • Adults With stuttering 15 to 40 years according to WHO criteria

You may not qualify if:

  • \- Stammering with any comorbid are excluded eg. Visual and Hearing Impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Muaz Medical Complex

Lahore, Punjab Province, 54000, Pakistan

Location

Related Publications (2)

  • Månsson H. Childhood stuttering: Incidence and development. Journal of fluency disorders. 2000;25(1):47-57.

    BACKGROUND
  • Eslami Jahromi M, Ahmadian L, Bahaadinbeigy K. The effect of tele-speech therapy on treatment of stuttering. Disabil Rehabil Assist Technol. 2022 Jan;17(1):34-39. doi: 10.1080/17483107.2020.1754475. Epub 2020 Apr 17.

    PMID: 32299263BACKGROUND

MeSH Terms

Conditions

Stuttering

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mamona Riaz, M.S

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2025

First Posted

April 22, 2025

Study Start

March 20, 2025

Primary Completion

June 20, 2025

Study Completion

June 29, 2025

Last Updated

July 15, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations